• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Efficacy of liposomal amphotericin B in the treatment of visceral leishmaniasis in patients coinfected with the human immunodeficiency virus.

作者信息

Torre-Cisneros J, Villanueva J L

出版信息

Clin Infect Dis. 1995 Jan;20(1):191. doi: 10.1093/clinids/20.1.191.

DOI:10.1093/clinids/20.1.191
PMID:7727652
Abstract
摘要

相似文献

1
Efficacy of liposomal amphotericin B in the treatment of visceral leishmaniasis in patients coinfected with the human immunodeficiency virus.脂质体两性霉素B治疗合并人类免疫缺陷病毒感染患者内脏利什曼病的疗效
Clin Infect Dis. 1995 Jan;20(1):191. doi: 10.1093/clinids/20.1.191.
2
Efficacy of intermittent liposomal amphotericin B in the treatment of visceral leishmaniasis in patients infected with human immunodeficiency virus.间歇性脂质体两性霉素B治疗人类免疫缺陷病毒感染患者内脏利什曼病的疗效
Clin Infect Dis. 1995 Sep;21(3):711-2. doi: 10.1093/clinids/21.3.711.
3
Efficacy of liposomal amphotericin B in the treatment and secondary prophylaxis of visceral leishmaniasis in HIV infected patients: report of two cases.脂质体两性霉素B治疗和二级预防HIV感染患者内脏利什曼病的疗效：两例报告
J Antimicrob Chemother. 1993 Oct;32(4):657-9. doi: 10.1093/jac/32.4.657.
4
Successful treatment of antimony-resistant visceral leishmaniasis with liposomal amphotericin B in patients infected with human immunodeficiency virus.脂质体两性霉素B成功治疗感染人类免疫缺陷病毒患者的耐锑内脏利什曼病。
Clin Infect Dis. 1993 Oct;17(4):625-7. doi: 10.1093/clinids/17.4.625.
5
Liposomal amphotericin B for the treatment of visceral leishmaniasis.脂质体两性霉素B用于治疗内脏利什曼病。
Clin Infect Dis. 2006 Oct 1;43(7):917-24. doi: 10.1086/507530. Epub 2006 Aug 28.
6
Visceral leishmaniasis in HIV infected patients: treatment with high dose liposomal amphotericin B (AmBisome).HIV感染患者的内脏利什曼病：高剂量脂质体两性霉素B（安必素）治疗
J Infect. 1996 Mar;32(2):133-7. doi: 10.1016/s0163-4453(96)91343-2.
7
Liposomal amphotericin B (AmBisome) in Mediterranean visceral leishmaniasis: a multi-centre trial.脂质体两性霉素B（安必素）治疗地中海内脏利什曼病：一项多中心试验。
Q J Med. 1994 Feb;87(2):75-81.
8
Diffuse cutaneous dissemination of visceral leishmaniasis during human immunodeficiency virus (HIV) infection, despite negligible immunodeficiency: repeated failure of liposomal amphotericin B administration, followed by successful long-term pentamidine and paromomycin administration.尽管免疫缺陷程度可忽略不计，但在人类免疫缺陷病毒（HIV）感染期间仍发生了内脏利什曼病的弥漫性皮肤播散：脂质体两性霉素B给药多次失败，随后成功长期给予喷他脒和巴龙霉素。
Int J Antimicrob Agents. 2008 Jun;31(6):590-2. doi: 10.1016/j.ijantimicag.2008.02.007. Epub 2008 May 5.
9
Liposomal amphotericin B and rHuGM-CSF for treatment of visceral leishmaniasis in AIDS.脂质体两性霉素B和重组人粒细胞巨噬细胞集落刺激因子用于治疗艾滋病患者的内脏利什曼病。
Infez Med. 2004 Sep;12(3):197-204.
10
Cutaneous manifestations of visceral leishmaniasis resistant to liposomal amphotericin B in an HIV-positive patient.一名HIV阳性患者中对脂质体两性霉素B耐药的内脏利什曼病的皮肤表现
Arch Dermatol. 2006 Jun;142(6):787-9. doi: 10.1001/archderm.142.6.787.

引用本文的文献

1
Comparison of the efficacies of various formulations of amphotericin B against murine visceral leishmaniasis.两性霉素B不同制剂对小鼠内脏利什曼病疗效的比较。
Antimicrob Agents Chemother. 1997 Oct;41(10):2089-92. doi: 10.1128/AAC.41.10.2089.
2
In vivo efficacy of oral and intralesional administration of 2-substituted quinolines in experimental treatment of new world cutaneous leishmaniasis caused by Leishmania amazonensis.2-取代喹啉经口服和病灶内给药对亚马逊利什曼原虫引起的新大陆皮肤利什曼病进行实验性治疗的体内疗效。
Antimicrob Agents Chemother. 1996 Nov;40(11):2447-51. doi: 10.1128/AAC.40.11.2447.